Structural and molecular conservation of glucagon-like Peptide-1 and its receptor confers selective ligand-receptor interaction
Val/Val homozygotes have attenuated response to oxidative stress but, paradoxically, sometimes better response to specific chemotherapies because tumor cells share the deficit
Some surgeons are aware of peptide use among their patients and report faster than expected healing in certain cases
Alkaliptosis has demonstrated potent antitumor activity, particularly in PDAC, and offers a promising therapeutic strategy for malignancies resistant to conventional therapies [63,64,65,66]
Bernstein et al., 2005
On- and Off-label Use of GLP-1 and GIP/GLP-1 RAs* *GLP-1 and GIP/GLP-1 RAs include: Bydureon, Byetta, Victoza, Ozempic, Rybelsus, Adlyxin, Saxenda, Wegovy, Zepbound, Trulicity, Mounjaro